Key result
Early home anistreplase increases pre-hospital reperfusion ~74% vs in-hospital administration.
Why the study?
The benefits of thrombolysis are believed to be related to the speed of reperfusion, but evidence for reperfusion occurring before hospital admission was sought.
Does early domiciliary administration of anistreplase improve pre-hospital reperfusion rates compared to in-hospital administration in patients with suspected acute myocardial infarction?
RCT (n=311)
Double-blind
randomized
Does early domiciliary administration of anistreplase improve pre-hospital reperfusion rates compared to in-hospital administration in patients with suspected acute myocardial infarction?
Absolute Risk Reduction: 25 (95% CI 8–42)
Absolute Event Rate: 59% vs 34%
Absolute Risk Reduction: 25%
p-value: p=0.003
Pre-hospital administration of thrombolysis significantly increases the rate of early reperfusion compared to in-hospital administration in patients with acute myocardial infarction.
Supports pre-hospital thrombolysis in suspected AMI; confirms randomized benefit of earlier administration for reperfusion.
The benefits of thrombolysis are believed to be related to the speed of reperfusion of the infarct-related artery. In this sub-study, evidence for the occurrence of reperfusion before admission to hospital has been sought. In a randomized double-blind controlled trial, 311 patients with suspected acute myocardial infarction were given anistreplase 30 units i.v., either at home at a median 101 min (early group, n = 163), or in hospital at a median 240 min after symptom onset (large group, n = 148). Paired electrocardiograms recorded at home and on admission to hospital were available for study in 143 and 137 patients in early and late groups. Reduction in ST elevation between home and hospital electrocardiograms of > 25% in a single lead was taken as evidence of reperfusion. Patients with significant ST elevation in either electrocardiogram comprised the sub-study groups, and numbered 63/143 (44%) and 68/137 (50%) in early and late groups respectively. A reduction of > 25% in the single lead demonstrating greatest ST elevation on the presenting electrocardiogram was observed in 37/63 (59%) and 23/68 (34%) patients in the early and late sub-study groups (difference 25%, 95% confidence interval 8% to 42%, P = 0.003). It was found that domiciliary thrombolysis was associated with electrocardiographic evidence of an increased rate of reperfusion occurring before admission to hospital. Evidence of reperfusion occurring pre-hospital, whether spontaneous or following thrombolytic therapy, was associated with a better outcome.
No takes yet. Share an insight, caveat, or question.
Trent et al. (1994) conducted an RCT in suspected acute myocardial infarction (n=311). Anistreplase at home (early) vs. Anistreplase in hospital (late) was evaluated on Reduction in ST elevation between home and hospital electrocardiograms of > 25% in a single lead (difference 25%, 95% CI 8% to 42%, p=0.003). Early home administration of anistreplase increased the rate of pre-hospital reperfusion compared to in-hospital administration (59% vs 34%; difference 25%, 95% CI 8% to 42%; P=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: